Home – Hydrochlorothiazide
Hydrochlorothiazide
REMEDYREPACK INC.
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
HYDROCHLOROTHIAZIDE DESCRIPTION
CLINICAL PHARMACOLOGY
PHARMACOKINETICS AND METABOLISM
PHARMACODYNAMICS
CLINICAL STUDIES
INDICATIONS & USAGE
HYDROCHLOROTHIAZIDE CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
DRUG INTERACTIONS
DRUG & OR LABORATORY TEST INTERACTIONS
PRECAUTIONS, GeneralCARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
PREGNANCY
Teratogenic Effects:
Nonteratogenic Effects:
NURSING MOTHERS
PEDIATRIC USE
GERIATRIC USE
HYDROCHLOROTHIAZIDE ADVERSE REACTIONS
PRECAUTIONSWARNINGSOVERDOSAGE
DOSAGE FORMS & STRENGTHS
HOW SUPPLIED
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Hydrochlorothiazide
Hydrochlorothiazide CAPSULE
Product Information
|
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:49349-721(NDC:23155-045) |
|
Route of Administration
|
ORAL |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
|
Ingredient Name
|
Basis of Strength
|
Strength
|
|
HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE |
|
12.5 mg
|
Product Characteristics
|
|
Color
|
Size
|
Imprint Code
|
Shape
|
|
turquoise |
15 mm |
HP45 |
CAPSULE |
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
NDC:49349-721-02 |
30 in 1 BLISTER PACK |
|
|
|
2 |
NDC:49349-721-28 |
300 in 1 CANISTER |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
ANDA |
ANDA040807 |
2011-08-30 |
|
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
